Summary of findings: levofloxacin for inhalation solution vs tobramycin
Adverse events: number of treatment‐related adverse events · adults and children aged over 12 with CF and P aeruginosa
1 finding from 1 review
- Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 282 participantsHigh